Global Drug Discovery Informatics Market is projected to

Visiongain has published a new report entitled the Drug Discovery Informatics Market Report 2021-2031. It includes profiles of Drug Discovery Informatics and Forecasts Market Segment by Type (Drug Development, Drug Discovery) Market Segment by Phase (Preclinical Testing, Clinical Trials Phase, Other Phase) Market Segment by End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Research Institutes, Other End-User) Market Segment by Function (Target Data, Sequencing & Target Data Analysis, Docking, Molecular Modeling, High Throughput Screening (HTS), Other Function) Market Segment by Technique (Computer-Assisted Synthesis Design (CASD), Structure Representation, Chemmetrics, Other Technique) PLUS COVID-19 Impact Analysis and Recovery Pattern Analysis (V-shaped, W-shaped, U-shaped, L-shaped) Profiles of Leading Companies, Region and Country.

The global drug discovery informatics market was valued at US$1987 million in 2020 and is projected to grow at a CAGR of 9.0% during the forecast period 2021-2031.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/drug-discovery-informatics-market-2021/#download_sampe_div

How has COVID-19 had a significant negative impact on the Drug Discovery Informatics Market?

The COVID-19 pandemic has had an influence on all stages of drug development, forcing several drug development companies and clinical research organizations (CROs) to halt at least part – and in many cases all – of their clinical trials. While stopping clinical research is not uncommon (especially early in development), never before have so many organizations suffered a disruption of this size at the same time. Despite this, sponsors of halted studies are still looking for methods to move their programs forward by taking proactive steps to guarantee their studies are ready to resume when conditions improve.

The new reality of government-mandated stay-at-home orders, social distance,…